Israel-based patient monitoring technology provider EarlySense extended its series F round to $25m on Tuesday after securing $5m from diversified conglomerate Mitsui.
Mitsui supplied the capital as part of an agreement to market EarlySense’s patient monitoring device to hospitals across Japan. Under the terms of the agreement, Mitsui will be the exclusive partner in Japan for EarlySense’s contact-free heart and respiratory rate monitor.
EarlySense secured $20m in January this year in the first tranche of a series F round led by Samsung Ventures Israel, the local corporate venturing subsidiary of electronics conglomerate Samsung.
Medical device maker Welch Allyn, charitable organisation Noaber Foundation, Pitango Venture Capital, JK&B and Proseed Venture Capital Fund also participated in the first series F tranche.
EarlySense’s monitor can be placed under a mattress to provide early detection of a patient’s deterioration, though it has also targeted the wellness market where the device can be used to improve sleep.
The company has now raised $71m across eight rounds. Welch Allyn formed a strategic partnership with the company in 2013.